JP2011519917A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011519917A5 JP2011519917A5 JP2011508424A JP2011508424A JP2011519917A5 JP 2011519917 A5 JP2011519917 A5 JP 2011519917A5 JP 2011508424 A JP2011508424 A JP 2011508424A JP 2011508424 A JP2011508424 A JP 2011508424A JP 2011519917 A5 JP2011519917 A5 JP 2011519917A5
- Authority
- JP
- Japan
- Prior art keywords
- disorder
- anxiety
- nervous system
- central nervous
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000019901 Anxiety disease Diseases 0.000 claims 2
- 208000015114 central nervous system disease Diseases 0.000 claims 2
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 claims 2
- 208000008811 Agoraphobia Diseases 0.000 claims 1
- 208000007848 Alcoholism Diseases 0.000 claims 1
- 208000000103 Anorexia Nervosa Diseases 0.000 claims 1
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 claims 1
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 claims 1
- 206010003805 Autism Diseases 0.000 claims 1
- 208000020706 Autistic disease Diseases 0.000 claims 1
- 206010006550 Bulimia nervosa Diseases 0.000 claims 1
- 208000001640 Fibromyalgia Diseases 0.000 claims 1
- 201000004311 Gilles de la Tourette syndrome Diseases 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 208000002193 Pain Diseases 0.000 claims 1
- 208000027030 Premenstrual dysphoric disease Diseases 0.000 claims 1
- 206010036618 Premenstrual syndrome Diseases 0.000 claims 1
- 208000012322 Raynaud phenomenon Diseases 0.000 claims 1
- 201000001880 Sexual dysfunction Diseases 0.000 claims 1
- 206010041250 Social phobia Diseases 0.000 claims 1
- 208000000323 Tourette Syndrome Diseases 0.000 claims 1
- 208000016620 Tourette disease Diseases 0.000 claims 1
- 206010046543 Urinary incontinence Diseases 0.000 claims 1
- QCWUMWNVBHIJGB-UHFFFAOYSA-N [4-[2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenoxy] dihydrogen phosphate Chemical compound C1CCCCC1(O)C(CN(C)C)C1=CC=C(OOP(O)(O)=O)C=C1 QCWUMWNVBHIJGB-UHFFFAOYSA-N 0.000 claims 1
- 201000007930 alcohol dependence Diseases 0.000 claims 1
- 230000036506 anxiety Effects 0.000 claims 1
- 208000015802 attention deficit-hyperactivity disease Diseases 0.000 claims 1
- 208000030963 borderline personality disease Diseases 0.000 claims 1
- 229960003920 cocaine Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 206010016256 fatigue Diseases 0.000 claims 1
- 238000011010 flushing procedure Methods 0.000 claims 1
- 208000035231 inattentive type attention deficit hyperactivity disease Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 208000030459 obsessive-compulsive personality disease Diseases 0.000 claims 1
- 208000019906 panic disease Diseases 0.000 claims 1
- 208000028173 post-traumatic stress disease Diseases 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 201000000980 schizophrenia Diseases 0.000 claims 1
- 231100000872 sexual dysfunction Toxicity 0.000 claims 1
- 230000000283 vasomotion Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020080043034A KR100965527B1 (ko) | 2008-05-08 | 2008-05-08 | 신규(4-(2-(디메틸아미노)-1-(1-하이드록시사이클로헥실)에틸)페녹시)포스페이트 또는 이의 약학적으로 허용가능한 염,이의 제조방법 및 이를 유효성분으로 함유하는 중추신경계질환 예방 및 치료용 조성물 |
| KR10-2008-0043034 | 2008-05-08 | ||
| PCT/KR2009/002426 WO2009136756A2 (ko) | 2008-05-08 | 2009-05-08 | 신규 {4-[2-(디메틸아미노)-1-(1-하이드록시사이클로헥실)에틸]페녹시}포스페이트 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 중추신경계 질환 예방 및 치료용 약학적 조성물 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011519917A JP2011519917A (ja) | 2011-07-14 |
| JP2011519917A5 true JP2011519917A5 (enExample) | 2012-06-07 |
Family
ID=41265177
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011508424A Pending JP2011519917A (ja) | 2008-05-08 | 2009-05-08 | 新規な｛４−［２−（ジメチルアミノ）−１−（１−ヒドロキシシクロヘキシル）エチル］フェノキシ｝ホスファートまたはその薬学的に許容可能な塩、その製造方法及びそれを有効成分として含む、中枢神経系疾患の予防及び治療用薬学的組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8334277B2 (enExample) |
| EP (1) | EP2287171A4 (enExample) |
| JP (1) | JP2011519917A (enExample) |
| KR (1) | KR100965527B1 (enExample) |
| CN (1) | CN102015736A (enExample) |
| WO (1) | WO2009136756A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2013011884A (es) | 2011-04-12 | 2013-11-21 | Lupin Ltd | Composiciones farmaceuticas de liberacion modificada de desvenlafaxina. |
| CN109761826B (zh) * | 2019-01-17 | 2022-02-25 | 烟台大学 | 一种o-去甲基文拉法辛苯醚化合物及其制备方法和用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4535186A (en) | 1983-04-19 | 1985-08-13 | American Home Products Corporation | 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives |
| ES2273764T3 (es) | 1993-06-28 | 2007-05-16 | Wyeth | Nuevos tratamientos que utilizan derivados de fenetilamina. |
| US5530013A (en) | 1994-02-14 | 1996-06-25 | American Home Products Corporation | Venlafaxine in the inducement of cognition enhancement |
| US5506270A (en) | 1995-01-30 | 1996-04-09 | American Home Products Corporation | Venlafaxine in the treatment of hypothalamic amenorrhea in non-depressed women |
| US5554383A (en) | 1995-04-06 | 1996-09-10 | Trustees Of Tufts College | Veterinary method for clinically modifying the behavior of dogs exhibiting canine affective aggression |
| US6274171B1 (en) | 1996-03-25 | 2001-08-14 | American Home Products Corporation | Extended release formulation of venlafaxine hydrochloride |
| US6197828B1 (en) | 1998-12-01 | 2001-03-06 | Sepracor, Inc. | Derivatives of (+)-venlafaxine and methods of preparing and using the same |
| US6348494B1 (en) | 2000-11-21 | 2002-02-19 | American Home Products Corporation | Ethers of o-desmethyl venlafaxine |
| NZ539791A (en) * | 2001-02-12 | 2006-11-30 | Wyeth Corp | Novel succinate salt of o-desmethyl-venlafaxine |
| WO2003082805A1 (en) * | 2002-03-28 | 2003-10-09 | Synthon B.V. | Low water-soluble venlafaxine salts |
| US20070098797A1 (en) | 2005-06-02 | 2007-05-03 | Biovail Laboratories International S.R.L. | Modified release composition of at least one form of venlafaxine |
-
2008
- 2008-05-08 KR KR1020080043034A patent/KR100965527B1/ko not_active Expired - Fee Related
-
2009
- 2009-05-08 JP JP2011508424A patent/JP2011519917A/ja active Pending
- 2009-05-08 WO PCT/KR2009/002426 patent/WO2009136756A2/ko not_active Ceased
- 2009-05-08 EP EP09742862A patent/EP2287171A4/en not_active Withdrawn
- 2009-05-08 CN CN2009801165278A patent/CN102015736A/zh active Pending
- 2009-05-08 US US12/990,972 patent/US8334277B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2500337A3 (en) | Solid form comprising (-) o-desmethylvenlafaxine and uses thereof | |
| JP2011524850A5 (enExample) | ||
| NZ621824A (en) | Rsv- specific binding molecules and means for producing them | |
| EP2514764A3 (en) | Antibody molecules which bind IL-17A and IL-17F | |
| NZ592850A (en) | Granulate of gamma-hydroxybutyric acid | |
| JP2006143749A5 (enExample) | ||
| RU2012127770A (ru) | Полициклические соединения и способы их применения | |
| WO2009117515A3 (en) | Novel compounds advantageous in the treatment of central nervous system diseases and disorders | |
| JP2012508275A5 (enExample) | ||
| WO2009149485A3 (en) | Compounds for treating amyloidoses | |
| ECSP088104A (es) | Inhibidor de la retoma dual de norepinefrina y serotonina altamente selectivo y su uso | |
| JP2009538870A5 (enExample) | ||
| EP3189836A3 (en) | Desferrioxamine-metal complexes for the treatment of immune-related disorders | |
| JP2008525553A5 (enExample) | ||
| JP2011519917A5 (enExample) | ||
| BR112014002859A2 (pt) | purificação pós-processamento para produção de gama-butiro lactona | |
| EP1904046A4 (en) | COMBINATIONS OF ESZOPICLON AND O-DESMETHYLVENLAFAXINE AND METHOD FOR THE TREATMENT OF MENOPAUSE AND HUMOR FLUCTUATIONS; ANXIETY AND COGNITIVE INTERFERENCE | |
| JP2008535860A5 (enExample) | ||
| JP2009526816A5 (enExample) | ||
| EP2596866A3 (de) | Dampfreinigung schwach saurer Kationenaustauscherharze | |
| WO2007058998A3 (en) | Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties | |
| JP2012517437A5 (enExample) | ||
| WO2002088136A3 (en) | Antidepressant azaheterocyclylmethyl derivatives of 1,4,5-trioxa-phenanthrene | |
| JP2010513391A5 (enExample) | ||
| RU2007102291A (ru) | Способ лечения расстройств и заболеваний нервной системы |